STUDIES OF THE DEPENDENCE-PRODUCING POTENTIAL OF THE NARCOTIC ANTAGONIST 2-CYCLOPROPYLMETHYL-2'-HYDROXY-5,9-DIMETHYL-6,7-BENZOMORPHAN (CYCLAZOCINE, WIN-20,740, ARC II-C-3)
The DOI matches its Crossref record.
Abstract
The effects of single doses and chronic administration of cyclazocine have been studied in nontolerant postaddicts, as well as in postaddicts physically dependent upon morphine. In addition, cyclazocine has been compared with morphine sulfate and nalorphine hydrochloride. Single dose studies indicate that cyclazocine produces a degree of euphoria, and that maximal euphoric effects are produced with doses of the order of magnitude of 1 mg/70 kg. The subjective effects produced by cyclazocine, however, are qualitatively different from those produced by morphine and most closely resemble those of nalorphine. In addition, larger doses of cyclazocine (1.0 and 2.0 mg/70 kg) produced certain effects which resembled, at least superficially, those produced by barbiturates. Cyclazocine does not suppress abstinence in subjects physically dependent on morphine; on the contrary, it precipitates abstinence in a manner similar to that of nalorphine. Subjects chronically intoxicated with 13.2 mg/70 kg/day of cyclazocine, using a gradually progressing dose schedule, showed definite evidence of tolerance to cyclazocine, cross tolerance to nalorphine, and exhibited a definite abstinence syndrome when cyclazocine was withdrawn. The predominant signs of abstinence from cyclazocine consisted of an increase in body temperature, mydriasis, loss of appetite, decrease in body weight, and tachycardia. The abstinence syndrome was slow in developing, first becoming apparent on the third or fourth day following withdrawal, and reaching a maximum on the seventh day of abstinence. Minimal signs of abstinence were seen as long as 6 weeks following withdrawal. The abstinence syndrome was qualitatively different from that from morphine. Although cyclazocine produces a type of euphoria, tolerance, and physical dependence, the bulk of evidence indicates that this agent is qualitatively different from morphine. In general, the effects of cyclazocine most closely resembled those of nalorphine. In conclusion, cyclazocine should not be classified as a morphine-like analgesic and its potential for abuse by narcotic addicts is regarded as being very low. Whether it would be abused on the basis of other pharmacologic properties, particularly for its sedative characteristics, cannot be predicted on the basis of these experiments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782
Naltrexone, an Antagonist for the Treatment of Heroin Dependence: Effects in Man
Martin, W. R. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750360022003 · Cited by 392
Self-citationKOSTERLITZ, H. W., & WATT, A. J. (1968) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1968.tb00988.x · Cited by 388
Pfaus, J. G., & Gorzalka, B. B. (1987) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(87)80002-7 · Cited by 271
Martin, W. R. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750320112017 · Cited by 264
Self-citation
Metadata
- Authors
- Martin, W. R., Fraser, H. F., Gorodetzky, C. W., & Rosenberg, D. E.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1965-12
- Volume
- 150
- Issue
- 3
- Pages
- 426-436
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2120957381
- Cited by
- 126
- References
- 0
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: STUDIES OF THE DEPENDENCE-PRODUCING POTENTIAL OF THE NARCOTIC ANTAGONIST 2-CYCLOPROPYLMETHYL-2'-HYDROXY-5,9-DIMETHYL-6,7-BENZOMORPHAN (CYCLAZOCINE, WIN-20,740, ARC II-C-3). https://app.cochat.ai/papers/10.1016/s0022-3565(25)27207-x
- The paper
- Martin, W. R., Fraser, H. F., Gorodetzky, C. W., & Rosenberg, D. E. (1965). STUDIES OF THE DEPENDENCE-PRODUCING POTENTIAL OF THE NARCOTIC ANTAGONIST 2-CYCLOPROPYLMETHYL-2'-HYDROXY-5,9-DIMETHYL-6,7-BENZOMORPHAN (CYCLAZOCINE, WIN-20,740, ARC II-C-3). The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(25)27207-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.